1. Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral;Badagliacca;J Heart Lung Transplant,2012
2. 2015 ESC/ERS guidelines for the diagnosis and management of pulmonary hypertension;Galie;Eur. Heart J.,2016
3. Abstract 2765: Maintenance of improvement in 6-minute walk distance with long-term bosentan treatment: results of BREATHE-1 open-label extension study;Badesch;Circulation,2006
4. A short-term delay of endothelin receptor antagonist therapy results in a decreased long-term improvement in exercise capacity, Poster presented at: CHEST;Waxman,2009
5. Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2);Rubin;Eur. Respir. J.,2015